I have  expertise in tumor immunology and use of antibodies in targeting tumor cells.  I am involved in a project studying the effect of oncolytic in tumor therapy and their efficacy in inducing an immune therapeutic effect. I am also participating in studies designed to determine the mechanisms and best combination regimens for oncolytic therapy  with immune modulation in vivo in spontaneous mouse models of cancer.